Fmoc-D-Agp(Boc)2-OH

Fmoc-D-Agp(Boc)2-OH is a D-configured, Fmoc-protected amino acid derivative bearing a side-chain guanidino group masked as two Boc carbamates, yielding a strongly protected, base-stable building block for peptide chemistry. The molecule contains an Fmoc group on the α-nitrogen for orthogonal N-protection, a free carboxylic acid for C-terminal coupling, and a chiral center that preserves stereochemical identity during synthesis. The Boc-protected guanidino functionality modulates nucleophilicity and reduces undesired side reactions during activation and coupling, while remaining compatible with standard acid-mediated deprotection strategies. The combination of aromatic Fmoc chromophore and protected guanidine chemistry supports both controlled peptide assembly and downstream conversion to a cationic, hydrogen-bonding residue in larger biomolecular constructs.

1. Protected Amino Acid Chemistry

Fmoc-D-Agp(Boc)2-OH serves as a protected amino acid derivative for orthogonally protected synthesis workflows where guanidino reactivity must be suppressed during peptide coupling. The Fmoc carbamate on the α-amine enables base-labile N-deprotection, while the carboxylic acid supports activation to form amide bonds under peptide coupling conditions. The double Boc masking on the side-chain guanidine provides a controlled protecting-group strategy that can be removed under acidic conditions to regenerate the strongly basic guanidinium functionality post-assembly. The resulting residue can be incorporated into peptide building sequences to study charge-dependent recognition, salt-bridge formation, and stereochemically defined side-chain geometry in amino acid chemistry and synthetic methodology.

2. Peptide Synthesis

Fmoc-D-Agp(Boc)2-OH functions as a peptide building block for solid-phase peptide synthesis and related protected amino acid coupling strategies targeting guanidino-containing sequences. The Fmoc group supports iterative N-terminal deprotection cycles, while the α-carboxylic acid participates in amide bond formation to extend the peptide chain with stereochemical fidelity at the D-center. The Boc-protected guanidine side chain minimizes competing nucleophilic reactions during activation, helping maintain sequence integrity when assembling longer peptides or densely functionalized segments. After peptide assembly, orthogonal deprotection can restore the guanidinium group, enabling formation of cationic peptide analogs suitable for downstream biochemical research intermediate preparation and peptide analog construction.

3. Chemical Biology And Bioconjugation

Fmoc-D-Agp(Boc)2-OH supports chemical biology applications where controlled introduction of a guanidino-bearing residue is required for molecular recognition and labeling chemistry. The protected guanidine motif can be converted to a positively charged side chain after deprotection, enabling electrostatic interactions and hydrogen-bonding patterns that influence binding to nucleic acids, proteins, or cell-surface components in assay-ready constructs. The Fmoc-protected α-amino acid framework allows incorporation into peptide tags, linkers, or constrained peptidomimetic scaffolds that can be further functionalized for conjugation workflows. The stereodefined D-configuration provides a handle for designing charge presentation and backbone stereochemistry in biomolecule modification and chemical probe development.

4. Peptidomimetics And SAR Studies

Fmoc-D-Agp(Boc)2-OH can be applied to peptidomimetic construction and structure-activity relationship studies requiring a guanidino side chain with controlled stereochemistry and delayed deprotection. The orthogonally protected architecture allows assembly of analog libraries where the guanidine charge is introduced at a defined stage, supporting systematic variation of residue placement and local electrostatics. The Fmoc-protected α-amino acid format facilitates incorporation into peptide-like scaffolds that can be cyclized, diversified, or appended to fragments for SAR-driven optimization. The downstream availability of a cationic guanidinium residue enables evaluation of binding determinants tied to side-chain basicity, hydrogen-bonding capacity, and D-amino acid stereochemical effects.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-D-Agp(Boc)2-OH is suitable as a process chemistry intermediate for manufacturing routes that require protected guanidino amino acid building blocks for peptide-based active ingredients or peptide intermediates. The Fmoc group provides a robust N-protection strategy compatible with industrial peptide synthesis operations, while the carboxylic acid supports standardized coupling chemistry in controlled manufacturing sequences. The Boc-protected guanidine reduces side reactions during intermediate handling and can be removed to generate the desired cationic functionality in downstream steps. The defined stereochemistry and orthogonal protecting-group design support reproducible intermediate preparation for fine chemical synthesis and specialty chemical production where peptide building block consistency is critical.

6. Analytical Research Standards

Fmoc-D-Agp(Boc)2-OH can be used in analytical research as a stereochemically defined, protected amino acid standard for method development and characterization of guanidino-containing peptide fragments. The Fmoc chromophore enables convenient detection in chromatographic workflows, while the protected guanidine reduces heterogeneity during sample preparation compared with partially deprotected species. The presence of both an α-carboxylic acid and protected side-chain functionality supports targeted derivatization or coupling controls when validating peptide coupling chemistry and deprotection endpoints. The compound's structure aligns with analytical needs for verifying identity, monitoring protected-to-deprotected transformations, and supporting reference material generation in biochemical research intermediate characterization.

1. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

2. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

3. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L

4. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

5. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate